DJIA 17,131.97 100.83 0.59%
NASDAQ 4,552.76 33.86 0.75%
S&P 500 1,998.98 14.85 0.75%
market minute promo

355.47 9.44 (2.73%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $355.47 2.73%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $346.82
Previous Close $346.03
Daily Range $345.00 - $356.21
52-Week Range $257.69 - $369.31
Market Cap $35.9B
P/E Ratio 98.30
Dividend (Yield) $0.00 (0.0%)
Volume 821,393
Average Daily Volume 648,234
Current FY EPS $7.95

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

Two Promising Gene Therapy Stocks Tackling Eye Disease

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Bayer/Regeneron Looking for Eylea Label Expansion in Japan - Analyst Blog

Sanofi: Riding The Growth Trend

There Is Further Upside Potential In Regeneron Pharmaceuticals

Nasdaq 100 Movers: REGN, YHOO

3 Reasons Sanofi's Stock Could Fall

In 2014, Sanofi has been executing a well thought out plan to recover its bout with the patent cliff. That said, the company isn't out of the woods yet. Here are three reasons why Sanofi shares may be in trouble moving forward.

Cramer's Mad Money - 3 Wide Receiver Stocks (9/4/14)

See More REGN News...

REGN's Top Competitors

REGN $355.47 (2.73%)
Current stock: REGN
AMGN $139.33 (0.99%)
Current stock: AMGN
GILD $104.76 (3.73%)
Current stock: GILD
BIIB $326.88 (2.11%)
Current stock: BIIB